ArticleCancer immunology, immunotherapy : CII2019

Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.

Yi-Hui Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.